News Daily News FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting Michael O'Riordan March 14, 2016
News Daily News Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR Michael O'Riordan March 14, 2016
News Daily News As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR Michael O'Riordan March 14, 2016
News Daily News ¿Relaja el Acuerdo de la FDA con Amarin el Control de las Promociones Fuera de Indicación? Michael O'Riordan March 09, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Daily News El Controvertido Ensayo LIGHT Ahora Publicado No Arroja Luz sobre los Riesgos CV de Contrave Michael O'Riordan March 08, 2016
News Daily News Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave Michael O'Riordan March 08, 2016
News Daily News Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease Michael O'Riordan March 07, 2016
News Daily News Optimal Risk Factor Control Translates Into Less Expenditure on Healthcare, Use of Resources Michael O'Riordan March 02, 2016
News Daily News Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics Michael O'Riordan March 01, 2016
News Daily News Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling Michael O'Riordan March 01, 2016
News Daily News Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel Michael O'Riordan February 28, 2016
News Daily News ‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis Michael O'Riordan February 28, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2016 Shelley Wood February 28, 2016
News Daily News Macrolide Antibiotics: No Link With Increased Risk of Ventricular Arrhythmia, Mortality in Cohort Study Michael O'Riordan February 25, 2016